首页> 美国卫生研究院文献>Rare Tumors >Metastasizing pleomorphic adenoma presenting as an asymptomatic kidney tumor twenty-nine years after parotidectomy – urological viewpoint and overview of the literature to date
【2h】

Metastasizing pleomorphic adenoma presenting as an asymptomatic kidney tumor twenty-nine years after parotidectomy – urological viewpoint and overview of the literature to date

机译:腮腺切除术后二十九年的转移性多形性腺瘤表现为无症状肾肿瘤–泌尿外科的观点和迄今为止的文献综述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pleomorphic adenomas (benign mixed tumors) are the most common tumors of glandular origin in the head and neck and are one of the few benign neoplasms that can undergo malignant transformation. Mixed tumors that are seemingly benign at the microscopic level but metastasize have been termed metastasizing mixed tumors (MZMTs). The entity of metastasizing benign mixed tumors has been reported since the early 1940s, with up to approximately 50 cases described in the literature to date. Despite their bland morphologic appearance, MZMTs have been associated with an overall mortality rate of about 20–40%. We report the case of a MZMT of the kidney almost 30 years after lateral parotidectomy owing to the same tumor entity. For benign mixed tumors, we are unaware of more than two other cases of metastasis to the kidney that have been published, whereas metastases to the bone, lung, and lymph nodes are more common. Parotidectomy is widely accepted as the first choice of treatment, but once metastases have occurred the therapeutic strategy is uncertain with surgery being the only curative option in cases with resectable disease. This case report provides information about the rare event of metastatic disease to the kidney and points out therapeutic strategies. However, in view of the general lack of adequate information in the literature, the best therapy for systemic disease still remains unresolved.
机译:多形性腺瘤(良性混合瘤)是头颈部最常见的腺源性肿瘤,也是少数可发生恶性转化的良性肿瘤之一。 在显微镜下看来良性的混合瘤水平但转移已被称为转移性混合瘤(MZMT)。自1940年代初以来就已经报道了转移良性混合肿瘤的实体,迄今已有多达50例文献报道。尽管MZMT具有平淡无奇的外观,但其总死亡率约为20-40%。我们报告了由于相同的肿瘤实体,在侧腮腺切除术后将近30年的肾脏MZMT病例。对于良性混合肿瘤,我们不知道有两个以上的肾脏转移病例,而骨,肺和淋巴结转移更为常见。腮腺切除术已被广泛接受为首选治疗方法, ,但一旦发生转移,治疗策略尚不确定,手术是可切除疾病的唯一治疗选择。该病例报告提供了有关肾脏转移性疾病罕见事件的信息,并指出了治疗策略。然而,鉴于文献中普遍缺乏足够的信息,针对全身性疾病的最佳疗法仍未解决。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号